Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07772596

An Artificial Intelligence-Powered Supportive Care Chatbot to Address the Supportive Care Needs of Young Adult Cancer Survivors

This clinical trial studies whether an artificial intelligence (AI)-powered supportive care chatbot is helpful for addressing the supportive care needs of young adult cancer survivors. Young adult cancer survivors often experience ongoing and distressing symptoms following treatment, including extreme tiredness and lack of energy, anxiety, and difficulty sleeping. Young adult cancer survivors report a variety of strategies to self-manage these symptoms; however, there remains a gap in targeted interventions focused on the needs in young adult survivors. The AI-powered supportive care chatbot is designed to provide evidence-based information on supportive care for young adult cancer survivors. Users interact with the chatbot by entering free-text questions or selecting from predefined topics to receive tailored educational responses related to supportive care across the cancer continuum, including treatment effects, symptom management, care transitions, and life after cancer. The AI-powered supportive care chatbot may be an effective way to help address the supportive care needs of young adult cancer survivors.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–39 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, 48109, United States

Location contact

Robert Knoerl

CONTACT

[email protected]

734-764-8617

Robert Knoerl

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 - 39 years old
  • Able to speak/read English
  • Completed primary cancer treatment (e.g., surgery, radiation, chemotherapy, immunotherapy) at least one month prior to the time of consent. Although, participants will be eligible if they are receiving maintenance treatments
  • Report at least one moderate to severe symptom, side effect, or supportive care concern from cancer or its treatment
  • Able to access Wi-Fi/internet
  • Willing to complete surveys electronically

Exclusion criteria

  • Completed cancer treatment more than three years ago

Treatment and study plan

Artificial Intelligence-based Intervention

Other

Interact with AI-powered supportive care chatbot

Other names: AI Intervention, AI-based Intervention

interview

Other

Ancillary studies

Survey Administration

Other

Ancillary studies

Primary outcomes

  1. Acceptability of AI-powered supportive care chatbot

    Time frame: At end of intervention, assessed up to 12 weeks

    Acceptability will be supported if mean scores on the Acceptability E-Scale are ≥ 4 (on a 5-point scale). Will be described (i.e., means, medians, standard deviations, and ranges) at the post-intervention time point.

  2. Demand of AI-powered supportive care chatbot

    Time frame: Up to 12 months

    Demand will be demonstrated by successful recruitment of the target sample (N=30) within 12 months.

  3. Implementation of AI-powered supportive care chatbot

    Time frame: During intervention use, assessed up to 12 weeks

    Implementation will be assessed by engagement with the chatbot, defined as ≥ 70% of participants reporting at least one use per week during the initial 4-week period, rather than a fixed duration of use, given the self-directed nature of the intervention. Will be described (i.e., means, medians, standard deviations, and ranges) weekly. Given the pilot nature of the study, no hypothesis testing or formal comparisons will be conducted.

  4. Retention

    Time frame: Up to 12 weeks

    Retention will be considered feasible if ≥ 80% of participants complete 4-week assessments, and ≥ 50% elect to continue to the optional extended use period.

  5. Usability of AI-powered supportive care chatbot

    Time frame: At end of intervention, assessed up to 12 weeks

    Usability will be supported if mean System Usability Scale scores are ≥ 70, indicating acceptable usability. Will be described (i.e., means, medians, standard deviations, and ranges) at the post-intervention time point.

  6. Patient Reported Outcomes Measurement Information System measure

    Time frame: At baseline, 4 weeks, and/or 12 weeks

    Will be summarized using descriptive statistics (e.g., means, medians, standard deviations, and ranges) at each time point. Changes over time (baseline, post-intervention, as applicable) will be examined descriptively.

  7. Digital Health Literacy Scale

    Time frame: At baseline

    Will be summarized using descriptive statistics (e.g., means, medians, standard deviations, and ranges) at the baseline time point. The Digital Health Literacy Scale is a 0 to 12 point score (based on 3 items), with higher scores indicating greater digital health care literacy.

  8. Interview themes and subthemes

    Time frame: At end of intervention, assessed up to 12 weeks

    The audio-recorded interviews will be transcribed verbatim by a professional transcription company and verified for accuracy by another study team member. The finalized transcripts will be imported into NVivo 12 (QSR International Pty Ltd). Inductive content analysis will be used to analyze the interview transcripts. Two study team members will review the transcripts and the interview guide to create an initial list of codes. Three transcripts will be independently coded using the initial codebook. After three interviews are coded, two study team members will meet to resolve any coding discrepancies and to revise the codebook further. The same process will be repeated after three more interviews are coded. After the codebook is finalized, one study team member will code the remaining interviews. Subsequently, the study team will meet as a group to review the transcripts in their entirety, making sense of the data and generating potential major themes and subthemes.

Study contacts

Contact information is provided by the study sponsor or research team.

Robert Knoerl

CONTACT

[email protected]

734-764-8617

Sponsors and collaborators

Lead sponsor

University of Michigan Rogel Cancer Center

Other

Registry information

Official study title

Feasibility, Usability, and Acceptability of an AI-Powered MASCC Supportive Care Platform Among Young Adults With Cancer

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Aug 19, 2026
Registry last updated
Aug 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.